title: What are the treatment options for paroxysmal extreme pain disorder?
authors.forename: Marc R
authors.initials: MR
authors.lastname: Suter
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D055724:Electrophysiological Phenomena / Q000235:genetics; D005544:Forecasting; D006801:Humans; D009154:Mutation / Q000235:genetics; D062556:NAV1.7 Voltage-Gated Sodium Channel / Q000235:genetics / Q000502:physiology; D010146:Pain / Q000235:genetics / Q000517:prevention & control*; D012007:Rectum / Q000002:abnormalities*; D026941:Sodium Channel Blockers / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D062556:NAV1.7 Voltage-Gated Sodium Channel; D026941:Sodium Channel Blockers; D002220:Carbamazepine
keywords: Nav1.7; erythromelalgia; pain neuropathic; paroxysmal extreme pain disorder; sodium channel